Market Access
The Inflation Reduction Act Passed, Now What?
In April 2022, we released an article describing proposed policies from the federal government ...
5 Ways Your Market Access Strategy Can Create a Better-Connected Patient Experience
Market access stands at the cusp of a golden opportunity to help increase healthcare ...
The Hidden Facts About Voucher and Bridge Pricing
The healthcare industry is rife with hidden revenue streams, specifically within the patient affordability ...
Inflationary Impact on Employer-Sponsored Health Coverage: Will a Recession be Different this Time?
Providing all Americans with access to affordable, quality healthcare is one of the most significant ...
Global Biopharma Launches in the New World Order
Biopharma blockbusters in the last 10 years show a disturbing trend. On average, they ...
It Takes a Village: How Pharma Can Help Address the Mental Health and Substance Abuse Crisis
The COVID-19 pandemic led to an increase in depression and anxiety, along with an ...
Importance of Ambulatory Surgery Centers to the Medical Device Industry
Philips, Siemens, DePuy, Boston Scientific. A simple Google search on the topic of ambulatory ...
Potential Policy Changes that Could Upend Prescription Drug Pricing
On November 3, 2021, Congress introduced a working draft of the Build Back Better ...
Roadmap to Improved Coverage and Access for Specialty Products
As specialty pharmaceutical products are becoming increasingly complex due to more technology-driven drug development, ...
Improving Your Patient Support Programs for Expanded Affordability
Patient support programs (PSPs), patient assistant programs (PAPs), copay coupons, or whatever name you ...
Establishing a Successful Pharma-Payer Relationship in 2022
If a life sciences company wants to start their relationship with a payer off ...
Two Key Questions About Payer Strategies in 2022
PM360 asked experts in dealing with payers to tell us the optimal strategies for ...
The Economic Burden of Rare Diseases and Need for Improved Policy
Rare diseases represent a major societal issue with significant costs. An estimated 400 million ...
